Antiviral Drugs Market Size

Antiviral Drugs Market size was over USD 56.69 billion in 2024 and is likely to reach USD 95.1 billion by the end of 2037, witnessing around 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of antiviral drugs is assessed at USD 58.55 billion.

The increasing cases of hepatitis B infection and high investment in R&D activities on antiviral drugs across the world are estimated to propel the market growth during the forecast period. As per the World Health Organization, about 296 million people are suffered from chronic hepatitis B infection in 2019.

The growing incidence rate of infectious diseases such as herpes simplex virus, hepatitis virus, and influenza. As per the observations, between September to October 2022, nearly 5300 members tested positive for the influenza virus.